3D超声精准医疗。

Ghobad Azizi, Michelle L Mayo, Lorna L Ogden, Jessica Farrell, Kele Piper, Carl Malchoff
{"title":"3D超声精准医疗。","authors":"Ghobad Azizi,&nbsp;Michelle L Mayo,&nbsp;Lorna L Ogden,&nbsp;Jessica Farrell,&nbsp;Kele Piper,&nbsp;Carl Malchoff","doi":"10.1089/ve.2023.0016","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>A 56-year-old woman was referred for thyroid nodules (TNs) found on a carotid ultrasonography (US). Her laboratories showed a normal thyroid stimulation hormone of 1.530 µIU/mL, normal thyroid hormone levels, and her thyroid antibodies were not elevated. Thyroid 2D US showed an isoechoic solid TN with regular margins measuring 12 × 8 × 10 mm (TR3) in the left thyroid lobe. 3D US demonstrated markedly irregular margins. The nodule volume was 0.52 cm<sup>3</sup>. Based on current American Thyroid Association and American College of Radiology-Thyroid Imaging, Reporting and Data System (ACR-TIRADS) guidelines, her nodule size would not fit the criteria for fine needle aspiration biopsy (FNAB).<sup>1,2</sup> However, because of the irregular margins seen on 3D US, FNAB was offered along with repeat US after 6 months. After considering her options, she requested FNAB. She underwent effective US guided FNAB of the left TN and the cytopathology report indicated follicular neoplasm Bethesda category IV. Subsequently, she had follow-up US guided FNAB for molecular testing with the Afirma's gene sequencing classifier (GSC). The report showed GSC suspicious with an NRAS mutation, indicating a 50% malignancy risk. She elected to have left hemithyroidectomy. The final surgical pathology report demonstrated a 12-mm follicular carcinoma.</p><p><strong>Materials and methods: </strong>In our thyroid clinic, we utilize conventional 2D US and 3D US to evaluate TN for possible FNAB. Laboratory measurements were performed at Labcorp. Informed consent was given by the patient. The 3D image acquisition follows 2D US examination. The first step in 3D US image acquisition is identifying the target nodule utilizing 2D US. Next, the 3D sweep of the target nodule produces a 3D volume data set and observation of 3D-rendered images generated simultaneously from longitudinal, transverse, and coronal views. A 2D US image displays a TN only on one plane in two dimensions, longitudinal or transverse. The saved 3D volume data set can be viewed and manipulated later. We can reconstruct new images from different angles after the study is completed. The 3D image acquisition direction (front to back versus up to down) will create a different display image and volume slice. The examiner can choose the direction of 3D acquisition before 3D sweep. A 2D US image or machine lacks these qualities.</p><p><strong>Discussion: </strong>This case illuminates recent advances in 3D US imaging and demonstrates that this technology may enhance the value of 2D US in diagnosing malignancy. This technology allows the user to create sequential cross-sectional images through the target nodule. The addition of coronal view to the existing 2D US has been an important contributing factor. Several recent publications have reported that 3D US can improve nodule selection criteria for FNAB.<sup>3-5</sup> Our clinic has routinely utilized 3D US technology for the past 4 years. We have learned that this new technology can delineate TN borders more clearly. It not only enhances the observation of structures within but also those attached to the thyroid gland. The target nodule can be rotated and viewed from different angles. The margin irregularities of TNs can be viewed with 3D US in small and large nodules equally. We have found that the 3D US shows the irregular margins of malignant TNs to be more pronounced when compared with high-end 2D US systems. In our experience, the vast majority of benign TNs have regular margins on 3D US. Finally, the 3D volume measurement may provide additional information about the size of TNs for longitudinal follow-up of nodules with benign FNAB. The limitations or challenges of using 3D US in general practice include the cost of the ultrasound machine, lack of reimbursement, and the provider's learning curve. Adding 3D/4D technology to current 2D US does provide more detailed information; however, it requires additional time to complete a thyroid US study. 3D US technology might be more suitable for thyroid clinics or endocrine practices with high patient volumes.</p><p><strong>Conclusion: </strong>We conclude that 3D US can enhance observation of TN margin irregularities and potentially improve nodule selection for FNAB.</p><p><p>No competing financial interests exist.</p><p><p>Runtime of video: 2 hrs 25 mins 12 secs.</p>","PeriodicalId":75302,"journal":{"name":"VideoEndocrinology","volume":"10 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345280/pdf/","citationCount":"0","resultStr":"{\"title\":\"Precision Medicine with 3D Ultrasound.\",\"authors\":\"Ghobad Azizi,&nbsp;Michelle L Mayo,&nbsp;Lorna L Ogden,&nbsp;Jessica Farrell,&nbsp;Kele Piper,&nbsp;Carl Malchoff\",\"doi\":\"10.1089/ve.2023.0016\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>A 56-year-old woman was referred for thyroid nodules (TNs) found on a carotid ultrasonography (US). Her laboratories showed a normal thyroid stimulation hormone of 1.530 µIU/mL, normal thyroid hormone levels, and her thyroid antibodies were not elevated. Thyroid 2D US showed an isoechoic solid TN with regular margins measuring 12 × 8 × 10 mm (TR3) in the left thyroid lobe. 3D US demonstrated markedly irregular margins. The nodule volume was 0.52 cm<sup>3</sup>. Based on current American Thyroid Association and American College of Radiology-Thyroid Imaging, Reporting and Data System (ACR-TIRADS) guidelines, her nodule size would not fit the criteria for fine needle aspiration biopsy (FNAB).<sup>1,2</sup> However, because of the irregular margins seen on 3D US, FNAB was offered along with repeat US after 6 months. After considering her options, she requested FNAB. She underwent effective US guided FNAB of the left TN and the cytopathology report indicated follicular neoplasm Bethesda category IV. Subsequently, she had follow-up US guided FNAB for molecular testing with the Afirma's gene sequencing classifier (GSC). The report showed GSC suspicious with an NRAS mutation, indicating a 50% malignancy risk. She elected to have left hemithyroidectomy. The final surgical pathology report demonstrated a 12-mm follicular carcinoma.</p><p><strong>Materials and methods: </strong>In our thyroid clinic, we utilize conventional 2D US and 3D US to evaluate TN for possible FNAB. Laboratory measurements were performed at Labcorp. Informed consent was given by the patient. The 3D image acquisition follows 2D US examination. The first step in 3D US image acquisition is identifying the target nodule utilizing 2D US. Next, the 3D sweep of the target nodule produces a 3D volume data set and observation of 3D-rendered images generated simultaneously from longitudinal, transverse, and coronal views. A 2D US image displays a TN only on one plane in two dimensions, longitudinal or transverse. The saved 3D volume data set can be viewed and manipulated later. We can reconstruct new images from different angles after the study is completed. The 3D image acquisition direction (front to back versus up to down) will create a different display image and volume slice. The examiner can choose the direction of 3D acquisition before 3D sweep. A 2D US image or machine lacks these qualities.</p><p><strong>Discussion: </strong>This case illuminates recent advances in 3D US imaging and demonstrates that this technology may enhance the value of 2D US in diagnosing malignancy. This technology allows the user to create sequential cross-sectional images through the target nodule. The addition of coronal view to the existing 2D US has been an important contributing factor. Several recent publications have reported that 3D US can improve nodule selection criteria for FNAB.<sup>3-5</sup> Our clinic has routinely utilized 3D US technology for the past 4 years. We have learned that this new technology can delineate TN borders more clearly. It not only enhances the observation of structures within but also those attached to the thyroid gland. The target nodule can be rotated and viewed from different angles. The margin irregularities of TNs can be viewed with 3D US in small and large nodules equally. We have found that the 3D US shows the irregular margins of malignant TNs to be more pronounced when compared with high-end 2D US systems. In our experience, the vast majority of benign TNs have regular margins on 3D US. Finally, the 3D volume measurement may provide additional information about the size of TNs for longitudinal follow-up of nodules with benign FNAB. The limitations or challenges of using 3D US in general practice include the cost of the ultrasound machine, lack of reimbursement, and the provider's learning curve. Adding 3D/4D technology to current 2D US does provide more detailed information; however, it requires additional time to complete a thyroid US study. 3D US technology might be more suitable for thyroid clinics or endocrine practices with high patient volumes.</p><p><strong>Conclusion: </strong>We conclude that 3D US can enhance observation of TN margin irregularities and potentially improve nodule selection for FNAB.</p><p><p>No competing financial interests exist.</p><p><p>Runtime of video: 2 hrs 25 mins 12 secs.</p>\",\"PeriodicalId\":75302,\"journal\":{\"name\":\"VideoEndocrinology\",\"volume\":\"10 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345280/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"VideoEndocrinology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1089/ve.2023.0016\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"VideoEndocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/ve.2023.0016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

简介:一名56岁女性因颈动脉超声检查发现甲状腺结节(TNs)而被转诊。她的实验室检查显示甲状腺刺激激素正常,1.530 μ IU/mL,甲状腺激素水平正常,甲状腺抗体未升高。甲状腺二维超声示左侧甲状腺叶12 × 8 × 10 mm (TR3)等回声实性TN。三维超声显示明显不规则边缘。结节体积0.52 cm3。根据目前美国甲状腺协会和美国放射学会甲状腺成像、报告和数据系统(ACR-TIRADS)指南,她的结节大小不符合细针穿刺活检(FNAB)的标准。1,2然而,由于在3D超声上看到不规则的边缘,6个月后,FNAB与重复超声一起提供。在考虑了她的选择之后,她要求FNAB。她接受了有效的左侧TN US引导FNAB,细胞病理学报告显示滤泡性肿瘤Bethesda IV类。随后,她接受了后续的US引导FNAB,用Afirma基因测序分类器(GSC)进行分子检测。报告显示GSC可疑的NRAS突变,表明50%的恶性风险。她选择了左甲状腺切除术。最后的手术病理报告显示一个12毫米的滤泡癌。材料和方法:在我们的甲状腺诊所,我们使用传统的二维超声和三维超声来评估TN是否可能有FNAB。实验室测量在Labcorp进行。患者给予知情同意。三维图像采集遵循二维超声检查。三维超声图像采集的第一步是利用二维超声识别目标结节。接下来,对目标结节进行3D扫描,生成3D体数据集,并观察同时从纵向、横向和冠状视图生成的3D渲染图像。二维美国图像仅在纵向或横向的一个平面上显示TN。保存的3D体数据集可以在以后查看和操作。在研究完成后,我们可以从不同的角度重建新的图像。3D图像采集方向(从前到后与从上到下)将创建不同的显示图像和体积切片。审查员可以在三维扫描前选择三维采集方向。2D美国图像或机器缺乏这些品质。讨论:本病例阐述了三维超声成像的最新进展,并表明该技术可以提高二维超声诊断恶性肿瘤的价值。该技术允许用户通过目标结节创建连续的横断面图像。将冠状视图添加到现有的2D US中是一个重要的促成因素。最近的一些出版物报道了3D超声检查可以改善fnab的结节选择标准。3-5我们的诊所在过去的4年里经常使用3D超声检查技术。我们了解到,这种新技术可以更清楚地描绘TN边界。它不仅增强了对甲状腺内部结构的观察,也增强了对甲状腺附属结构的观察。目标结节可以旋转并从不同角度观察。大小结节均可在三维超声下观察到结节边缘的不规则性。我们发现,与高端2D超声系统相比,3D超声显示恶性TNs的不规则边缘更为明显。根据我们的经验,绝大多数良性TNs在3D US上有规律的边缘。最后,三维体积测量可以为良性FNAB结节的纵向随访提供关于TNs大小的额外信息。在一般实践中使用3D超声的限制或挑战包括超声机器的成本,缺乏报销,以及提供者的学习曲线。将3D/4D技术添加到当前的2D US中确实提供了更详细的信息;然而,它需要额外的时间来完成甲状腺研究。3D US技术可能更适合甲状腺诊所或高患者量的内分泌实践。结论:三维超声可以增强对TN边缘不规则性的观察,并有可能改善FNAB的结节选择。不存在相互竞争的经济利益。影片时长:2小时25分12秒。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Precision Medicine with 3D Ultrasound.

Introduction: A 56-year-old woman was referred for thyroid nodules (TNs) found on a carotid ultrasonography (US). Her laboratories showed a normal thyroid stimulation hormone of 1.530 µIU/mL, normal thyroid hormone levels, and her thyroid antibodies were not elevated. Thyroid 2D US showed an isoechoic solid TN with regular margins measuring 12 × 8 × 10 mm (TR3) in the left thyroid lobe. 3D US demonstrated markedly irregular margins. The nodule volume was 0.52 cm3. Based on current American Thyroid Association and American College of Radiology-Thyroid Imaging, Reporting and Data System (ACR-TIRADS) guidelines, her nodule size would not fit the criteria for fine needle aspiration biopsy (FNAB).1,2 However, because of the irregular margins seen on 3D US, FNAB was offered along with repeat US after 6 months. After considering her options, she requested FNAB. She underwent effective US guided FNAB of the left TN and the cytopathology report indicated follicular neoplasm Bethesda category IV. Subsequently, she had follow-up US guided FNAB for molecular testing with the Afirma's gene sequencing classifier (GSC). The report showed GSC suspicious with an NRAS mutation, indicating a 50% malignancy risk. She elected to have left hemithyroidectomy. The final surgical pathology report demonstrated a 12-mm follicular carcinoma.

Materials and methods: In our thyroid clinic, we utilize conventional 2D US and 3D US to evaluate TN for possible FNAB. Laboratory measurements were performed at Labcorp. Informed consent was given by the patient. The 3D image acquisition follows 2D US examination. The first step in 3D US image acquisition is identifying the target nodule utilizing 2D US. Next, the 3D sweep of the target nodule produces a 3D volume data set and observation of 3D-rendered images generated simultaneously from longitudinal, transverse, and coronal views. A 2D US image displays a TN only on one plane in two dimensions, longitudinal or transverse. The saved 3D volume data set can be viewed and manipulated later. We can reconstruct new images from different angles after the study is completed. The 3D image acquisition direction (front to back versus up to down) will create a different display image and volume slice. The examiner can choose the direction of 3D acquisition before 3D sweep. A 2D US image or machine lacks these qualities.

Discussion: This case illuminates recent advances in 3D US imaging and demonstrates that this technology may enhance the value of 2D US in diagnosing malignancy. This technology allows the user to create sequential cross-sectional images through the target nodule. The addition of coronal view to the existing 2D US has been an important contributing factor. Several recent publications have reported that 3D US can improve nodule selection criteria for FNAB.3-5 Our clinic has routinely utilized 3D US technology for the past 4 years. We have learned that this new technology can delineate TN borders more clearly. It not only enhances the observation of structures within but also those attached to the thyroid gland. The target nodule can be rotated and viewed from different angles. The margin irregularities of TNs can be viewed with 3D US in small and large nodules equally. We have found that the 3D US shows the irregular margins of malignant TNs to be more pronounced when compared with high-end 2D US systems. In our experience, the vast majority of benign TNs have regular margins on 3D US. Finally, the 3D volume measurement may provide additional information about the size of TNs for longitudinal follow-up of nodules with benign FNAB. The limitations or challenges of using 3D US in general practice include the cost of the ultrasound machine, lack of reimbursement, and the provider's learning curve. Adding 3D/4D technology to current 2D US does provide more detailed information; however, it requires additional time to complete a thyroid US study. 3D US technology might be more suitable for thyroid clinics or endocrine practices with high patient volumes.

Conclusion: We conclude that 3D US can enhance observation of TN margin irregularities and potentially improve nodule selection for FNAB.

No competing financial interests exist.

Runtime of video: 2 hrs 25 mins 12 secs.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Correction to: Vocal Cord Monitoring by Flexible Fiberoptic Laryngoscopy During Thyroid Radiofrequency Ablation Videoendocrinology 2023 10(3): pp. 41–43; doi: 10.1089/ve.2023.0012 Vocal Cord Monitoring by Flexible Fiberoptic Laryngoscopy During Thyroid Radiofrequency Ablation. Advantages of TOETVA: A Remote Access Approach The Use and Abuse of Thyroid Hormone History of Thyroid Surgery in the Last Century
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1